Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02972047 · ClinicalTrials.gov registry record · NA
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02972047: Completed NA study, sponsored by Mayo Clinic.
NCT02972047 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02972047, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study aims to understand why patients have predominantly upright gastroesophageal reflux disease by comparing such patients to healthy persons AND whether a behavioral intervention (diaphragmatic breathing) will impact this disease
Interventions
- BEHAVIORAL Diaphragmatic Breathing
- BEHAVIORAL Sham Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-04-06 |
| Est. Completion | 2020-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02972047
The ClinicalTrials.gov registry entry for NCT02972047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diaphragmatic Breathing is the first listed.
NCT02972047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02972047 about?
NCT02972047 is a clinical study titled "Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux". This study aims to understand why patients have predominantly upright gastroesophageal reflux disease by comparing such patients to healthy persons AND whether a behavioral intervention (diaphragmatic breathing) will impact this disease
What is the current status of trial NCT02972047?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-04-06. Estimated completion is 2020-08-30.
What interventions are being tested in trial NCT02972047?
The interventions under investigation include: Diaphragmatic Breathing (BEHAVIORAL), Sham Comparator (BEHAVIORAL).
Who is sponsoring clinical trial NCT02972047?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.